Lv1
90 积分 2026-04-17 加入
Cracking the BAFF code
2天前
已完结
Time to response with ravulizumab, a long‐acting terminal complement inhibitor, in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis
15天前
已完结
Relationship between Low and High Anti-acetylcholine Receptor Antibody Titers and Clinical Severity in Myasthenia Gravis
15天前
已完结
Targeted molecular therapy for myasthenia gravis
3个月前
已完结
Real-world data in drug development strategies for orphan drugs: Tafasitamab in B-cell lymphoma, a case study for an approval based on a single-arm combination trial
3个月前
已完结
皖公网安备34019202002308
